Promoted by a pioneer of the Indian pharmaceuticals business, Mr. Amrut, Unichemical Labs has grown to become one of India’s most respected pharmaceutical companies. It is committed to delivering better health through superior products. By combining strategic research and in-depth industry knowledge, Unichem aims to transform itself into a global pharmaceutical drug company with an increasing focus on cutting-edge research and developed markets. With formulations forming the core of Unichemicals’s business, the company also manufactures active pharmaceutical ingredients (APIs or bulk actives). In addition, it has several pharma products that address relevant and growing therapeutic areas like gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterials, anti-infectives and pain management among others. INTERNATIONAL ACCREDITATIONS Backed by a highly capable and motivated team of nearly 3000 people, Unichem is headquartered in Mumbai, India, and has six drug manufacturing locations across the country. In keeping with its commitment to benchmark quality standards, several of the company’s facilities have been accredited by reputed international organizations such as the US FDA, ISO, UK MHRA (earlier MCA), MCC (South Africa), WHO (Geneva) and TGA (Australia). RESEARCH & DEVELOPMENT – THE NEXT FRONTIER The company has taken several important strides in the critical area of pharmaceuticals Research & Development (R&D). It has expanded its R&D facility in Mumbai to spearhead research in Novel Drug Delivery Systems (NDDS) and chemically synthesize non-infringing routes for the manufacture of medical products directed at regulated markets. In its effort to drive innovation, Unichem has established a proprietary Pharma Technology Development Centre in Goa to focus on the development of generic formulations comprising Immediate Release as well as NDDS and ANDAs exclusively for the US market. The facility has also been equipped to handle the development of formulation for New Chemical Entities (NCEs). Further, the company has also established Biotech facility at Goa to invent, design, develop and commercialize biotech and biosimilar products. With a robust business model, seamless processes and innovative research, Unichem is positioned to take on challenges of the future while remaining firmly rooted in a solid foundation of values. INSPIRED BY VALUES, DRIVEN BY VISION.

Promoted by a pioneer of the Indian pharmaceuticals business, Mr. Amrut, Unichemical Labs has grown to become one of India’s most respected pharmaceutical companies. It is committed to delivering better health through superior products. By combining strategic research and in-depth industry knowledge, Unichem aims to transform itself into a global pharmaceutical drug company with an increasing focus on cutting-edge research and developed markets. With formulations forming the core of Unichemicals’s business, the company also manufactures active pharmaceutical ingredients (APIs or bulk actives). In addition, it has several pharma products that address relevant and growing therapeutic areas like gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterials, anti-infectives and pain management among others. INTERNATIONAL ACCREDITATIONS Backed by a highly capable and motivated team of nearly 3000 people, Unichem is headquartered in Mumbai, India, and has six drug manufacturing locations across the country. In keeping with its commitment to benchmark quality standards, several of the company’s facilities have been accredited by reputed international organizations such as the US FDA, ISO, UK MHRA (earlier MCA), MCC (South Africa), WHO (Geneva) and TGA (Australia). RESEARCH & DEVELOPMENT – THE NEXT FRONTIER The company has taken several important strides in the critical area of pharmaceuticals Research & Development (R&D). It has expanded its R&D facility in Mumbai to spearhead research in Novel Drug Delivery Systems (NDDS) and chemically synthesize non-infringing routes for the manufacture of medical products directed at regulated markets. In its effort to drive innovation, Unichem has established a proprietary Pharma Technology Development Centre in Goa to focus on the development of generic formulations comprising Immediate Release as well as NDDS and ANDAs exclusively for the US market. The facility has also been equipped to handle the development of formulation for New Chemical Entities (NCEs). Further, the company has also established Biotech facility at Goa to invent, design, develop and commercialize biotech and biosimilar products. With a robust business model, seamless processes and innovative research, Unichem is positioned to take on challenges of the future while remaining firmly rooted in a solid foundation of values. INSPIRED BY VALUES, DRIVEN BY VISION.